Cargando…

Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity

Detalles Bibliográficos
Autores principales: Bouwman, Wilbert, Verhaegh, Wim, van de Stolpe, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115401/
https://www.ncbi.nlm.nih.gov/pubmed/37093950
http://dx.doi.org/10.3389/fphar.2023.1183639
_version_ 1785028206598815744
author Bouwman, Wilbert
Verhaegh, Wim
van de Stolpe, Anja
author_facet Bouwman, Wilbert
Verhaegh, Wim
van de Stolpe, Anja
author_sort Bouwman, Wilbert
collection PubMed
description
format Online
Article
Text
id pubmed-10115401
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101154012023-04-20 Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity Bouwman, Wilbert Verhaegh, Wim van de Stolpe, Anja Front Pharmacol Pharmacology Frontiers Media S.A. 2023-04-05 /pmc/articles/PMC10115401/ /pubmed/37093950 http://dx.doi.org/10.3389/fphar.2023.1183639 Text en Copyright © 2023 Bouwman, Verhaegh and van de Stolpe. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Bouwman, Wilbert
Verhaegh, Wim
van de Stolpe, Anja
Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
title Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
title_full Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
title_fullStr Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
title_full_unstemmed Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
title_short Corrigendum: Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity
title_sort corrigendum: improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-tnf alpha treatment based on measurement of signal transduction pathway activity
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115401/
https://www.ncbi.nlm.nih.gov/pubmed/37093950
http://dx.doi.org/10.3389/fphar.2023.1183639
work_keys_str_mv AT bouwmanwilbert corrigendumimproveddiagnosisofinflammatoryboweldiseaseandpredictionandmonitoringofresponsetoantitnfalphatreatmentbasedonmeasurementofsignaltransductionpathwayactivity
AT verhaeghwim corrigendumimproveddiagnosisofinflammatoryboweldiseaseandpredictionandmonitoringofresponsetoantitnfalphatreatmentbasedonmeasurementofsignaltransductionpathwayactivity
AT vandestolpeanja corrigendumimproveddiagnosisofinflammatoryboweldiseaseandpredictionandmonitoringofresponsetoantitnfalphatreatmentbasedonmeasurementofsignaltransductionpathwayactivity